Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07174037

Impact of Planter Flexors Spasticity on Postrual Stabilty and Functional Outcome in Pateints With Stroke

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
68 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
45 Years – 60 Years
Healthy volunteers
Not accepted

Summary

this study will be conducted to investigate the effect of planter flexors spasticity on postural stability, risk of falling and function outcomes in patients with stroke

Detailed description

Lower limb spasticity is a common following a cerebrovascular attack (CVA) or stroke, which can affect the balance and gait of patients. This then not only affects independence, and quality of life but increases the risk for other concerns, such as falling and an increased sedentariness, which could further affect health outcomes.The spasticity of the planter flexors disturbs walking, can impede toe clearance during the swing phase of gait causing the patient to fall as a result their toe 'catching' on the ground .In stroke patients characteristically the extensors of the leg are spastic and the flexors are weak . All these changes lead to gait disturbance as well as impaired functional mobility of patients.Studies have shown that patients with stroke have a higher risk of developing the fear of falling, which may be related to an increased risk of falling after stroke .The incidence of fear of falling after stroke has been reported to be approximately 32 to 66 percent. Fear of falling is associated with adverse consequences such as limited activity, increased incidence of falls, decreased quality of life, and increased hospitalization and case fatality rates

Conditions

Interventions

TypeNameDescription
OTHERLow spasticity grouplow sapsticity (grade 1-2) unilateral ischemic stroke will be participate in this group
OTHERHigh spasticity grouphigh sapsticity (grade 3-4) unilateral ischemic stroke will be participate in this group

Timeline

Start date
2025-09-20
Primary completion
2026-03-30
Completion
2026-03-30
First posted
2025-09-15
Last updated
2025-09-15

Source: ClinicalTrials.gov record NCT07174037. Inclusion in this directory is not an endorsement.